A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 3, 2013, Pages 371-381

  Goraya, Nimrit ^a,b   Simoni, Jan ^b   Jo, Chan Hee ^a,c   Wesson, Donald E ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; BICARBONATE; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM; SODIUM; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ADULT; AGED; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; FAT INTAKE; FEMALE; FOLLOW UP; FRUIT; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLIC ACIDOSIS; RADIOIMMUNOASSAY; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VEGETABLE;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADMINISTRATION, ORAL; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; DIET; FEMALE; FRUIT; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; POTASSIUM; RENAL INSUFFICIENCY, CHRONIC; SODIUM BICARBONATE; TEXAS; TIME FACTORS; TREATMENT OUTCOME; VEGETABLES;

EID: 84875046603     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02430312     Document Type: Article

References (38)

1. National Kidney Foundation: K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35: S1-S140, 2000
2. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM: Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084, 2009
3. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab H, Wesson DE: Amelioration of metabolic acidosis in individuals with low GFR reduces kidney endothelin production, reduces kidney injury, and better preserves GFR. Kidney Int 77: 617-623, 2010
4. Hsu CY, Chertow GM: Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17: 1419-1425, 2002
5. Remer T: Influence of nutrition on acid-base balance-metabolic aspects. Eur J Nutr 40: 214-220, 2001
6. US Renal Data System: USRDS 2009 Annual Data Report, Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
7. Appel LJ, Wright JT Jr, Greene T, Kusek JW, Lewis JB, Wang X, Lipkowitz MS, Norris KC, Bakris GL, Rahman M, Contreras G, Rostand SG, Kopple JD, Gabbai FB, Schulman GI, Gassman JJ, Charleston J, Agodoa LY; African American Study of Kidney Disease and Hypertension Collaborative Research Group: Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med 168: 832-839, 2008
8. Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE: Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int 78: 303-309, 2010
9. Goraya N, Simoni J, Jo C-H, Wesson DE: Dietary acid reduction with fruits and vegetables or sodium bicarbonate reduces kidney injury in individuals with moderately reduced GFR due to hypertensive nephropathy. Kidney Int 81: 86-93, 2011
10. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G; Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877-884, 1994
11. Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE: Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int 73: 192-199, 2008
12. RegaladoM, Yang S, Wesson DE: Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. Am J Kidney Dis 35: 687-694, 2000
13. Barsotti G, Morelli E, Cupisti A, Meola M, Dani L, Giovannetti S: A low-nitrogen low-phosphorus Vegan diet for patients with chronic renal failure. Nephron 74: 390-394, 1996
14. Remer T, Manz F: Potential renal acid load of foods and its influence on urine pH. J Am Diet Assoc 95: 791-797, 1995
15. Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M: Determination of ideal bodyweight for drug dosage calculations. Am J Hosp Pharm 40: 1016-1019, 1983
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, JonesDW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560-2572, 2003
17. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51: 395-406, 2008
18. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
19. Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 59: 1-8, 1999
20. 3 secretion. Am J Physiol 271: F132-F140, 1996
21. Cunarro JA, Weiner MW: A comparison of methods for measuring urinary ammonium. Kidney Int 5: 303-305, 1974
22. Costigan M, Rustom R, Shenkin A, Bone JM: Origin and significance of urinary N-acetyl b-D-glucosaminidase (NAG) in renal patients with variable function, pathology and proteinuria. Clin Chim Acta 255: 133-344, 1996
23. Wesson DE, Nathan T, Rose T, Simoni J, Tran RM: Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production. Kidney Int 71: 210-217, 2007
24. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P: Transforming growth factor-b 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 97: 3479-3484, 2000
25. Wesson DE, Simoni J: Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet. Kidney Int 78: 1128-1135, 2010
26. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988
27. AdevaMM, Souto G: Diet-induced metabolic acidosis. ClinNutr 30: 416-421, 2011
28. Frassetto LA, Todd KM, Morris RC Jr, Sebastian A: Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents. AmJ ClinNutr 68: 576-583, 1998
29. Pascual JM, Rodilla E, MirallesA, Gonzalez C, Redon J: Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens 24: 2277-2284, 2006
30. Rouse IL, Beilin LJ, Armstrong BK, Vandongen R: Vegetarian diet, blood pressure and cardiovascular risk. Aust N Z J Med 14: 439-443, 1984
31. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin P-H, Aickin M, Most-Windhauser MM, Moore TJ, Proschan MA, Cutler JA; DASH-Sodium Collaborative Research Group: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 344: 3-10, 2001
32. Swift PA, Markandu ND, Sagnella GA, He FJ, MacGregor GA: Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: A randomized control trial. Hypertension 46: 308-312, 2005
33. Weinberg JM, Appel LJ, BakrisG, Gassman JJ, Greene T, Kendrick CA, Wang X, Lash J, Lewis JA, Pogue V, Thornley-Brown D, Phillips RA; African American Study of Hypertension and Kidney Disease Collaborative Research Group: Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med 169: 1587-1594, 2009
34. Whelton PK: Potassium and blood pressure. In: Hypertension Primer, edited by Izzo JL Jr, Black HR, 3rd Ed., Dallas, American Heart Association Council on High Blood Pressure Research, 2003, pp 280-282
35. Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lazzari P, Derosa G: Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension. Hypertens Res 33: 236-242, 2010
36. Papadoyannakis NJ, Stefanidis CJ, McGeown M: The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr 40: 623-627, 1984
37. Schambelan M, Sebastian A, Biglieri EG: Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int 17: 89-101, 1980
38. Carlisle EJ, Donnelly SM, Ethier JH, Quaggin SE, Kaiser UB, Vasuvattakul S, Kamel KS, Halperin ML: Modulation of the secretion of potassium by accompanying anions in humans. Kidney Int 39: 1206-1212, 1991